SPDYE2: A Protein Involved in Cell-cell Adhesion and Cancer (G441273)

Target Name: SPDYE2

NCBI ID: G441273

SPDYE2

SPDYE2: A Protein Involved in Cell-cell Adhesion and Cancer

SPDYE2 (SPDE2_HUMAN) is a protein that is expressed in various tissues of the human body. It is a key regulator of cell-cell adhesion and has been implicated in a number of diseases, including cancer.

One of the key functions of SPDYE2 is its role in cell-cell adhesion. This protein helps to regulate the stickiness of cells to each other, which is important for the formation of tissues and organs and for the development of diseases.

SPDYE2 has also been shown to play a role in the regulation of cell proliferation. In fact, studies have suggested that high levels of SPDYE2 can promote the growth and proliferation of cancer cells.

In addition to its role in cell-cell adhesion and proliferation, SPDYE2 has also been implicated in a number of other processes in the body. For example, this protein has been shown to be involved in the regulation of neural development and in the development of certain diseases, such as Alzheimer's and Parkinson's.

Given its involvement in a number of important processes in the body, it is not surprising that SPDYE2 has been identified as a potential drug target. Researchers are currently working to develop new treatments for SPDYE2-related diseases, including cancer.

In addition to its potential as a drug target, SPDYE2 is also a potential biomarker. This protein has been shown to be expressed in a number of different types of cancer, including breast, ovarian, and prostate cancer. This suggests that it may be a useful diagnostic marker for these diseases.

Furthermore, SPDYE2 has also been shown to be involved in the regulation of cell signaling pathways. This suggests that it may be a useful target for drugs that are designed to disrupt these signaling pathways and prevent the development of cancer.

Overall, SPDYE2 is a protein that has the potential to be a drug target or biomarker for a number of different diseases. Further research is needed to fully understand its role in the body and to develop new treatments for SPDYE2-related conditions.

Protein Name: Speedy/RINGO Cell Cycle Regulator Family Member E2

The "SPDYE2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SPDYE2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets